Healthcare A sure bet Sector

Team Veye | 30-Apr-2018 Healthcare A sure bet Sector

Australia has long been considered a “Lucky Country” as life expectancy has continued to increase for Australians. Quality of life is on the rise, with living conditions improving thanks to advancements in vital sectors like health care.  Australia’s dual private-public health care system is highly regarded by most Australians. The private and public sectors are deeply interconnected and having private health insurance has largely become part of the Australian way of life. Despite the additional costs, 84% of Australians with private health insurance value the product and want to keep it. Our health system is also well regarded in terms of clinical outcomes. Australia is among the world’s best in terms of outcomes like infant mortality. The majority of the population (65%) believe the quality of the health system in their State or Territory is very high.

Government data shows the lifespan of both sexes has increased. People born in 2011–2013 are now tipped to live to around 33–34 years longer than Australians born between 1880 and 1890. So, on an average, we have gained an extra 34 years of life expectancy over the last 100 years, and with that, the prevalence of disease has shifted from acute self-limiting conditions to chronic illnesses, which can be treated, but not cured.

 

Utilisation of health services has increased dramatically as a result. Improvements in health technology have tended to add to health costs, not substitute for them, leading to a situation where the majority of health expenditure on a single patient occurs in the last year of their life. Consumer expectations of what the health system should deliver are increasing in line with economic growth and increased life expectancy. Many people who have a hip or knee replacement these days do so with the expectation of returning to work, not retiring.

Out of the major countries in the world, Australia ranks fourth.  Japan holds the 1st position closely followed by Switzerland and Iceland, although all countries are very close falling between the 82-84yrs range. With quality, outcomes, and value being the watchwords for health care in the 21st century, sector stakeholders around the globe are looking for innovative and cost-effective ways to deliver patient-centered, technology-enabled “smart” health care, both inside and outside hospital walls.

 

The trends for the healthcare sector remained strong in 2017 and we expect this momentum to continue into 2018, driven by - Friendly regulatory environment like the US FDA approving more drugs and increase in population mostly driven by Immigration that is likely to result in higher revenue generation for the companies in this sector and consequentially increasing the growth. It can well be concluded that the Healthcare sector is a sure bet sector, as long as the population is growing and human life expectancy improves.

Disclaimer

Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.

veye logo

Grab Your Free Report On 5 ASX Dividend Stocks To Buy In 2024

(+61)

SALE IS LIVE

Limited Time Deal:   Over 72% OFF

DIVIDEND
INVESTER REPORT

Dividend-Investor-Report

Each week we cover companies offering a good combination of growth & dividends, maintaining a balance between stable 'cash flow' and risker 'raising stars'. Our guidance helps you choose companies with regular dividends and opportunities for lower-risk capital growth.

  • The best High Yield Dividend Stocks picked by our team of analysts every week.
  • Detailed in-depth Analysis with our expert Recommendations Buy, Hold or Sell.
  • Free Daily Analysis Report to keep up with the latest on what's hot and what's not.
  • Gain instant access to a wide range of Dividend Share Reports, exclusive to members only.
Frequency: Every Tuesday